Announcements Trials
Browse Landscape

Status

Completed 31Terminated 11Unknown 3Withdrawn 2Active not recruiting 1

Sponsor Class

NIH 24OTHER 3NETWORK 2

Study Type

Observational 3

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Cancer Patients 2Peripheral Nervous System Diseases 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 349Oxaliplatin 260Capecitabine 258Radiotherapy 238Gemcitabine 221Docetaxel 221Carboplatin 220Drug Therapy 216Cyclophosphamide 216apatinib 200Paclitaxel 199Bevacizumab 194camrelizumab 189Fluorouracil 187sintilimab 131Irinotecan 125Blood Specimen Collection 124Dexamethasone 122Etoposide 118toripalimab 115Surgical Procedures, Operative 115Radiosurgery 114pembrolizumab 111Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 101Surveys and Questionnaires 98tislelizumab 96Doxorubicin 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT02428101 2023-11-28

Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer

Ain Shams University

Unknown
80 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Peripheral Nervous System Diseases

NCT04654195 2020-12-04

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

NCT04581967 2020-10-09

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡